Magnis Therapeutics, Omnis Pharma deal

Omnis and Magnis merged to form Vyriad (Rochester, Minn.). The company will combine Omnis’ vesicular stomatitis virus (VSV) and Magnis’ measles virus programs to identify therapies to treat cancer. ...